Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RNLX | US
0.00
0.38%
Healthcare
Health Information Services
31/03/2024
18/09/2024
0.29
0.30
0.30
0.28
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs including validated blood-based biomarkers inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis clinical care patient stratification for drug clinical trials and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health Wake Forest Baptist Health and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York New York.
View LessLow Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
70.6%1 month
117.3%3 months
137.7%6 months
121.2%-
-
18.77
-0.85
1.07
-1.36
11.62
-
-33.07M
24.12M
24.12M
-
-1.15K
-
-26.10
-1.07K
0.09
1.52
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.07
Range1M
0.16
Range3M
0.28
Rel. volume
0.10
Price X volume
27.98K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
LIFW | LIFW | Health Information Services | 0.1703 | 24.81M | 5.78% | n/a | 280.65% |
Gryphon Digital Mining Inc. | GRYP | Health Information Services | 0.51 | 20.62M | -1.92% | n/a | -136.32% |
Bullfrog AI Holdings Inc. Common Stock | BFRG | Health Information Services | 2.33 | 18.29M | 5.43% | n/a | 6.33% |
Streamline Health Solutions Inc | STRM | Health Information Services | 0.1763 | 11.16M | -1.34% | n/a | 36.82% |
CMAX | CMAX | Health Information Services | 2.18 | 8.32M | -0.46% | n/a | -347.33% |
Mangoceuticals Inc. Common Stock | MGRX | Health Information Services | 0.2401 | 7.18M | -2.83% | n/a | 1.92% |
Common Stock | ZCMD | Health Information Services | 1.25 | 3.15M | 0.00% | n/a | 4.49% |
Aclarion Inc | ACON | Health Information Services | 0.176 | 1.69M | -3.77% | n/a | 47.32% |
OTRKP | OTRKP | Health Information Services | 0.221 | 0 | 0.00% | n/a | 44.56% |
LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock | LFMDP | Health Information Services | 22.3601 | 0 | -1.50% | n/a | -494.85% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Feishang Anthracite Resources Limited | FSHRF | Coal | 0.011 | 19.46M | n/a | -145.80% | |
Tantech Holdings Ltd | TANH | Coal | 0.165 | 1.38M | 0.55% | 0.08 | 6.96% |
Watford Holdings Ltd | WTRE | Insurance - Diversified | 19.8376 | 0 | -0.61% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.36 | 14.87 | Cheaper |
Ent. to Revenue | 11.62 | 13.60 | Par |
PE Ratio | - | 61.44 | - |
Price to Book | 18.77 | 6.89 | Expensive |
Dividend Yield | - | 1.35 | - |
Std. Deviation (3M) | 137.68 | 79.36 | Riskier |
Debt to Equity | -0.85 | 0.45 | Cheaper |
Debt to Assets | 1.07 | 0.37 | Expensive |
Market Cap | 24.12M | 3.96B | Emerging |